These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37751487)
1. The value of folate receptor-positive circulating tumour cells as a diagnostic biomarker for lung cancer: a systematic review and meta-analysis. Chen F; Ni Y; Zhang J; Hao Y; Tian Z; Qiang G J Int Med Res; 2023 Sep; 51(9):3000605231199763. PubMed ID: 37751487 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of circulating tumor cells for lung cancer: A systematic review and meta-analysis. Ye Y; Li SL; Wang JJ; Liu B Medicine (Baltimore); 2019 Mar; 98(12):e14936. PubMed ID: 30896658 [TBL] [Abstract][Full Text] [Related]
4. Role of circulating tumor cells in diagnosis of lung cancer: a systematic review and meta-analysis. Zhao Q; Yuan Z; Wang H; Zhang H; Duan G; Zhang X J Int Med Res; 2021 Mar; 49(3):300060521994926. PubMed ID: 33682521 [TBL] [Abstract][Full Text] [Related]
5. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics. Xu Y; Li Q; Lin Z; Lin Y Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421 [TBL] [Abstract][Full Text] [Related]
6. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules. Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049 [TBL] [Abstract][Full Text] [Related]
7. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis. Cui C; Sun X; Zhang J; Han D; Gu J J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270 [TBL] [Abstract][Full Text] [Related]
8. Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis. Liu Y; Xing Z; Zhan P; Liu H; Ye W; Lv T; Song Y Medicine (Baltimore); 2016 Nov; 95(47):e5115. PubMed ID: 27893656 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis. Tang L; Zhao S; Liu W; Parchim NF; Huang J; Tang Y; Gan P; Zhong M BMC Cancer; 2013 Jun; 13():314. PubMed ID: 23806209 [TBL] [Abstract][Full Text] [Related]
10. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules. Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408 [TBL] [Abstract][Full Text] [Related]
11. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer. Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of programmed cell death-ligand 1 expression on circulating tumor cells in lung cancer: A systematic review and meta-analysis. Cui M; Wan Z; Yang J; Liao D; Yang Y; Xiang Y Int J Biol Markers; 2023 Dec; 38(3-4):159-166. PubMed ID: 37545433 [TBL] [Abstract][Full Text] [Related]
13. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study. Yan S; Guo W; Liu Y; Li K; Wang W Int J Clin Oncol; 2022 Mar; 27(3):538-544. PubMed ID: 35043284 [TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta-analysis. Huang H; Shi Y; Huang J; Wang X; Zhang R; Chen H Clin Respir J; 2018 Feb; 12(2):639-645. PubMed ID: 27778482 [TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer. He X; Chi Y; Peng J; Hu W; Ding C; Li B J Thorac Dis; 2022 Jun; 14(6):2103-2111. PubMed ID: 35813759 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study. Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831 [TBL] [Abstract][Full Text] [Related]
17. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer. Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596 [TBL] [Abstract][Full Text] [Related]
18. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis. Zhang L; Cao D; Tang L; Sun C; Hu Y Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study]. Lian H; Ding Z; Yuan D; Ma J; Qin J Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):813-820. PubMed ID: 27978866 [TBL] [Abstract][Full Text] [Related]
20. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness. Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]